$PKTX
ProtoKinetix, Inc.

2022 Q3 Form 10-Q Financial Statement

#000107997322000911 Filed on July 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $208.3K $338.5K $347.7K
YoY Change -83.98% -11.42% 282.0%
% of Gross Profit
Research & Development $161.0K $102.9K $163.1K
YoY Change 59.57% -4.89% 294.7%
% of Gross Profit
Depreciation & Amortization $750.00 $750.00 $750.00
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $370.0K $442.2K $511.5K
YoY Change -73.61% 9.52% 284.35%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$370.0K -$442.2K -$511.5K
YoY Change -73.61% -17.07% 284.35%
Income Tax
% Of Pretax Income
Net Earnings -$370.0K $442.2K -$511.5K
YoY Change -73.61% -209.52% 284.35%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$1.272K -$1.519K -$1.785K
COMMON SHARES
Basic Shares Outstanding 309.5M shares 291.0M shares
Diluted Shares Outstanding 291.0M shares 291.0M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.71K $18.83K $58.88K
YoY Change -69.92% -77.74% -76.48%
Cash & Equivalents $43.71K $18.83K $57.88K
Short-Term Investments
Other Short-Term Assets $1.050K $1.050K $1.050K
YoY Change 0.0% 0.0% 0.0%
Inventory
Prepaid Expenses $1.050K $1.050K
Receivables
Other Receivables
Total Short-Term Assets $44.76K $19.88K $59.93K
YoY Change -69.41% -76.79% -76.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $435.0K $393.2K $367.5K
YoY Change 28.15% 22.93% 18.93%
TOTAL ASSETS
Total Short-Term Assets $44.76K $19.88K $59.93K
Total Long-Term Assets $435.0K $393.2K $367.5K
Total Assets $479.7K $413.0K $427.4K
YoY Change -1.24% 1.86% -23.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $105.0K $36.78K $7.000K
YoY Change 40.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $105.0K $36.78K $7.000K
YoY Change 1400.47% 635.6% 40.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $105.0K $36.78K $7.000K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $105.0K $36.78K $7.000K
YoY Change 1400.43% 635.6% 40.0%
SHAREHOLDERS EQUITY
Retained Earnings -$46.86M -$46.49M
YoY Change
Common Stock $1.681K $1.641K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $374.7K $376.3K $426.6K
YoY Change
Total Liabilities & Shareholders Equity $479.7K $413.0K $427.4K
YoY Change -1.24% 1.86% -23.73%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$370.0K $442.2K -$511.5K
YoY Change -73.61% -209.52% 284.35%
Depreciation, Depletion And Amortization $750.00 $750.00 $750.00
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$157.5K -$163.6K -$336.3K
YoY Change 0.38% -52.46% 116.96%
INVESTING ACTIVITIES
Capital Expenditures -$42.57K -$26.41K -$5.580K
YoY Change 109.29% 128.26% -84.09%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$42.57K -$26.41K -$5.580K
YoY Change 109.29% 128.26% -84.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 225.0K 150.0K 343.2K
YoY Change -5.46% -21.05% 38.95%
NET CHANGE
Cash From Operating Activities -157.5K -163.6K -336.3K
Cash From Investing Activities -42.57K -26.41K -5.580K
Cash From Financing Activities 225.0K 150.0K 343.2K
Net Change In Cash 24.88K -40.05K 1.310K
YoY Change -59.01% -75.84% -97.7%
FREE CASH FLOW
Cash From Operating Activities -$157.5K -$163.6K -$336.3K
Capital Expenditures -$42.57K -$26.41K -$5.580K
Free Cash Flow -$115.0K -$137.2K -$330.7K
YoY Change -15.84% -58.74% 175.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
PKTX Issuance Of Common Stock Pursuant To Cashless Option Exercise Amount
IssuanceOfCommonStockPursuantToCashlessOptionExerciseAmount
usd
CY2021Q2 PKTX Issuance Of Common Stock Pursuant To Cashless Option Exercise Amount
IssuanceOfCommonStockPursuantToCashlessOptionExerciseAmount
usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3768 pure
PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001128189
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32917
dei Entity Registrant Name
EntityRegistrantName
PROTOKINETIX, INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3355026
dei Entity Address Address Line1
EntityAddressAddressLine1
412 Mulberry St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Marietta
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45750
dei City Area Code
CityAreaCode
740
dei Local Phone Number
LocalPhoneNumber
434-5041
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
309496818 shares
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
18830 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
57568 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
19880 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
83563 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
393162 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
CY2022Q2 us-gaap Assets
Assets
413042 usd
CY2021Q4 us-gaap Assets
Assets
446234 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
36780 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
93268 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
36780 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93268 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
306830151 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
306830151 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297393485 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
297393485 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1641 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1591 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
46869401 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45892545 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46494780 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45541170 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
376262 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413042 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446234 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
750 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
750 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56487 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
206587 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114538 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
247633 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
40139 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
29395 usd
us-gaap Professional Fees
ProfessionalFees
87892 usd
us-gaap Professional Fees
ProfessionalFees
62083 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102924 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108218 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
265974 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149531 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
241853 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
58785 usd
us-gaap Share Based Compensation
ShareBasedCompensation
483706 usd
us-gaap Share Based Compensation
ShareBasedCompensation
76062 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
442153 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
403735 usd
us-gaap Operating Expenses
OperatingExpenses
953610 usd
us-gaap Operating Expenses
OperatingExpenses
536809 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
442153 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-403735 usd
us-gaap Net Income Loss
NetIncomeLoss
-953610 usd
us-gaap Net Income Loss
NetIncomeLoss
-536809 usd
CY2022Q2 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2021Q2 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2022Q2 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
290989603 shares
CY2021Q2 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
290414046 shares
PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
282228660 shares
PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
282228660 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
493200 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
483706 usd
us-gaap Profit Loss
ProfitLoss
-953610 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
376262 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
426562 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
150000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
241853 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-442153 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
376262 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
424221 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
247001 usd
PKTX Issuance Of Common Stock Pursuant To Warrant Exercise
IssuanceOfCommonStockPursuantToWarrantExercise
190000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
76062 usd
us-gaap Profit Loss
ProfitLoss
-536809 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
400475 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
555425 usd
CY2021Q2 PKTX Issuance Of Common Stock Pursuant To Warrant Exercise
IssuanceOfCommonStockPursuantToWarrantExercise
190000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
58785 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-403735 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
400475 usd
us-gaap Net Income Loss
NetIncomeLoss
-953610 usd
us-gaap Net Income Loss
NetIncomeLoss
-536809 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1500 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1500 usd
PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
483706 usd
PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
76062 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-24945 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-56488 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-39960 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-499947 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-499207 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31991 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
46644 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31991 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46644 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
493200 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
437001 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
493200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
437001 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38738 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-108850 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57568 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193445 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18830 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84595 usd
CY2015 PKTX Payment To Acquire Intangible Assets
PaymentToAcquireIntangibleAssets
30000 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
CY2022Q2 us-gaap Deposits Assets
DepositsAssets
1050 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
1050 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_z9r6lIoHrz8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_864_zPhxlE5BmtPd">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P3Y6M25D
PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q4 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
24945 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
291186 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
90985 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
382171 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
31991 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
414162 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16500 usd
CY2021 PKTX Amortization
Amortization
3000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19500 usd
PKTX Amortization
Amortization
1500 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
393162 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31991 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
483706 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
76062 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4070 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94690000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
84690000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2107500 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
14800000 shares
CY2022Q2 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
500000000 shares
CY2021Q4 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
400000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q2 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2021Q4 us-gaap Dividends Receivable
DividendsReceivable
0 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
555556 shares
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
30000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
30000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
483706 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
0 usd
CY2022Q2 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
0 usd
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
0 usd

Files In Submission

Name View Source Status
0001079973-22-000911-index-headers.html Edgar Link pending
0001079973-22-000911-index.html Edgar Link pending
0001079973-22-000911.txt Edgar Link pending
0001079973-22-000911-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pktx-20220630.xsd Edgar Link pending
pktx-20220630_cal.xml Edgar Link unprocessable
pktx-20220630_def.xml Edgar Link unprocessable
pktx-20220630_lab.xml Edgar Link unprocessable
pktx-20220630_pre.xml Edgar Link unprocessable
pktx_10q-063022.htm Edgar Link pending
pktx_10q-063022_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending